Stocks · Health care · Pharmaceutical Preparations

ONCOLYTICS BIOTECH INC

ONCY Clue Score36
United States Fiscal year ends December CIK 0001129928

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Jared Kelly
12 Mar 2026
Chief Executive Officer
Buy
5,050
$0.96
$4.85K
James T. Parsons
11 Mar 2026
Director
Buy
10,000
$1.03
$10.30K
Patricia S Andrews
12 Feb 2026
Director
Buy
35,400
$0.86
$30.29K
Bernd R. Seizinger
12 Feb 2026
Director
Buy
40,000
$0.85
$33.86K
Allison Hagerman
12 Feb 2026
VP, Product Development
Buy
10,000
$0.83
$8.30K
Deborah Margaret Brown
12 Feb 2026
Director
Buy
25,000
$0.85
$21.24K
Thomas Charles Heineman
12 Feb 2026
Chief Medical Officer
Buy
12,132
$0.83
$10.03K
Wayne Pisano
12 Feb 2026
Director
Buy
30,000
$0.84
$25.34K
Kirk Look
12 Feb 2026
Chief Financial Officer
Buy
12,000
$0.84
$10.10K
Jared Kelly
12 Feb 2026
Chief Executive Officer
Buy
29,500
$0.84
$24.84K
Andrew Aromando
11 Feb 2026
Chief Business Officer
Buy
29,600
$0.86
$25.42K
Bernd R. Seizinger
11 Feb 2026
Director
Buy
60,000
$0.83
$49.59K
Jared Kelly
11 Feb 2026
Chief Executive Officer
Buy
5,600
$0.84
$4.68K
Bernd R. Seizinger
16 Jan 2026
Director
Buy
100,000
$1.04
$103.77K

What was left out

Form 4 filings counted 26
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 20 Jan 2026